R Squared Ltd Has $403,000 Stake in Plexus Corp. $PLXS

R Squared Ltd boosted its position in Plexus Corp. (NASDAQ:PLXS) by 84.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,980 shares of the technology company’s stock after buying an additional 1,360 shares during the period. R Squared Ltd’s holdings in Plexus were worth $403,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of PLXS. Fuller & Thaler Asset Management Inc. lifted its holdings in Plexus by 120.4% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock valued at $44,655,000 after buying an additional 190,360 shares during the period. Nuveen LLC bought a new stake in Plexus in the first quarter valued at $22,975,000. American Century Companies Inc. increased its stake in Plexus by 24.7% in the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company’s stock valued at $86,901,000 after purchasing an additional 134,205 shares in the last quarter. Millennium Management LLC increased its stake in Plexus by 85.1% in the first quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock valued at $29,229,000 after purchasing an additional 104,904 shares in the last quarter. Finally, Invesco Ltd. increased its stake in Plexus by 66.1% in the first quarter. Invesco Ltd. now owns 211,741 shares of the technology company’s stock valued at $27,130,000 after purchasing an additional 84,249 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Insider Activity at Plexus

In related news, insider Victor (Pang Hau) Tan sold 3,000 shares of the business’s stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $139.00, for a total transaction of $417,000.00. Following the transaction, the insider directly owned 8,723 shares in the company, valued at approximately $1,212,497. The trade was a 25.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Oliver K. Mihm sold 2,102 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $130.43, for a total transaction of $274,163.86. Following the transaction, the chief operating officer owned 21,155 shares in the company, valued at approximately $2,759,246.65. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,856 shares of company stock valued at $2,142,440 over the last quarter. 1.76% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have weighed in on PLXS. Wall Street Zen downgraded shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 19th. Williams Trading set a $165.00 price target on shares of Plexus in a research note on Monday, September 22nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Needham & Company LLC lifted their price target on shares of Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Benchmark reaffirmed a “buy” rating and issued a $165.00 price target on shares of Plexus in a research note on Friday. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $159.00.

Plexus Trading Down 4.0%

NASDAQ:PLXS opened at $143.92 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. The firm has a 50-day moving average of $141.04 and a 200-day moving average of $133.85. The company has a market cap of $3.88 billion, a PE ratio of 22.99 and a beta of 0.80. Plexus Corp. has a one year low of $103.43 and a one year high of $172.89.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, topping the consensus estimate of $1.84 by $0.30. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The firm’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.85 earnings per share. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, equities research analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.